RCT | Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military.
8 Jul, 2022 | 11:26h | UTCDose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial – Neuropsychopharmacology (if the link is paywalled, try this one)
Commentary on Twitter
Glad to see this work published. Contrary to predictions from small studies, #ketamine failed in the largest #PTSD clinical trial.
Future studies should test the lower dose and 3x/wk. @npp_journal @YalePsych @bcmhouston @netteaverillhttps://t.co/7NcFsNTMKw
— Chadi Abdallah (@ChadiAbdallah3) January 19, 2022